amphetamine has been researched along with neuropeptide y in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.41) | 18.7374 |
1990's | 4 (10.81) | 18.2507 |
2000's | 14 (37.84) | 29.6817 |
2010's | 17 (45.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beal, MF; Martin, JB; Riskind, PN; Tatsuoka, Y | 1 |
Bendotti, C; Garattini, S; Samanin, R | 1 |
Abrous, DN; Herman, JP; Le Moal, M | 1 |
Beninger, RJ; Merali, Z; Moore, E | 1 |
Beninger, RJ; Josselyn, SA | 1 |
Dang, DQ; Gillard, ER; Stanley, BG | 1 |
Brown, CM; Coscina, DV; Fletcher, PJ | 1 |
Matsumoto, AM; Sohn, EH; Wolden-Hanson, T | 1 |
Cheng, JT; Hsu, CT; Kuo, DY | 1 |
Cheng, JT; Inui, A; Kuo, DY | 1 |
Herman, ZS; Obuchowicz, E | 1 |
Kuo, DY | 1 |
Abdallah, L; Cannon, CM; During, MJ; Palmiter, RD; Tecott, LH | 1 |
Hsieh, YS; Kuo, DY; Yang, SF | 2 |
Bowyer, JF; Slikker, W | 1 |
Chiou, HL; Hsieh, YS; Kuo, DY; Yang, SF | 2 |
Gruber, SH; Mathé, AA; Nomikos, GG | 1 |
Chen, CH; Chu, SC; Hsieh, YS; Kuo, DY; Yang, SF | 1 |
Chen, CH; Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Yang, SF | 1 |
Chen, CH; Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Kuo, MH | 1 |
Bogus-Nowakowska, K; Kolenkiewicz, M; Majewski, M; Najdzion, J; Robak, A; Równiak, M; Wasilewska, B; Zakowski, W | 1 |
Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Kuo, MH; Yu, CH | 1 |
Chen, PN; Hsieh, YS; Kuo, DY; Liao, JM; Yu, CH | 1 |
Brown, JA; Ebert, P; Everheart, M; Garbett, KA; Gellért, L; Horváth, S; Mirnics, K; Schmidt, MJ | 1 |
Brown, J; Caprioli, RM; Ebert, P; Everheart, M; Garbett, KA; Gellert, L; Grice, TW; Horvath, S; Mirnics, K; Norris, JL; Schmidt, MJ; Seeley, EH | 1 |
Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Lin, MH; Lin, YH; Yu, CH | 1 |
Chen, PN; Hsieh, YS; Kuo, DY; Yu, CH | 1 |
Chen, PN; Chu, SC; Ho, YJ; Hsieh, YS; Kuo, DY; Yu, CH | 1 |
Chen, CH; Chen, PN; Hsieh, YS; Kuo, DY; Tsai, TT; Yu, CH | 1 |
Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Yu, CH | 4 |
Chen, JR; Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Yu, CH | 1 |
Abe, C; Hashimoto, H; Maruyama, T; Morita, H; Motojima, Y; Saito, R; Sonoda, S; Tanaka, Y; Ueno, H; Ueta, Y; Yoshimura, M | 1 |
37 other study(ies) available for amphetamine and neuropeptide y
Article | Year |
---|---|
The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus.
Topics: Amphetamine; Animals; Caudate Nucleus; Chromatography, High Pressure Liquid; Dopamine; Kinetics; Male; Neuropeptide Y; Peptides; Perfusion; Radioimmunoassay; Rats; Somatostatin; Somatostatin-28 | 1987 |
Eating caused by neuropeptide-Y injection in the paraventricular hypothalamus: response to (+)-fenfluramine and (+)-amphetamine in rats.
Topics: Amphetamine; Animals; Feeding Behavior; Female; Fenfluramine; Hypothalamus; Male; Neuropeptide Y; Rats; Rats, Inbred Strains; Starvation | 1987 |
The increase in striatal neuropeptide Y immunoreactivity induced by neonatal dopamine-depleting lesions in rats is reversed by intrastriatal dopamine-rich transplants.
Topics: Amphetamine; Animals; Animals, Newborn; Brain Tissue Transplantation; Denervation; Dopamine; Fetal Tissue Transplantation; Immunohistochemistry; Male; Mesencephalon; Neostriatum; Neural Pathways; Neurons; Neuropeptide Y; Oxidopamine; Rats; Rats, Wistar; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1994 |
Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats.
Topics: Amphetamine; Animals; Dopamine Antagonists; Flupenthixol; Male; Microinjections; Neostriatum; Neuropeptide Y; Rats; Rats, Wistar; Stereotyped Behavior | 1994 |
Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol.
Topics: Amphetamine; Animals; Conditioning, Operant; Flupenthixol; Injections; Male; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Wistar; Reward; Synaptic Transmission | 1993 |
Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake.
Topics: Amphetamine; Animals; Anorexia; Catecholamines; Dopamine; Eating; Epinephrine; Hypothalamus; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley | 1993 |
The rewarding properties of neuropeptide Y in perifornical hypothalamus vs. nucleus accumbens.
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Feeding Behavior; Food; Hypothalamus; Male; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Sucrose; Time Factors | 2000 |
Testosterone (T)-induced changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA are attenuated in old compared to young male brown Norway rats: contribution of T to age-related changes in cocaine-amphetamine-regulated transcript
Topics: Aging; Amphetamine; Animals; Arcuate Nucleus of Hypothalamus; Body Composition; Body Weight; Cocaine; Dopamine Uptake Inhibitors; Hypothalamus; In Situ Hybridization; Male; Nerve Tissue Proteins; Neuropeptide Y; Orchiectomy; Rats; Rats, Inbred BN; RNA, Messenger; Testosterone; Transcription, Genetic | 2002 |
Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine.
Topics: Amphetamine; Animals; Body Weight; Feeding Behavior; Hypothalamus; Male; Neuropeptide Y; Oligonucleotides, Antisense; Rats; Rats, Wistar | 2001 |
Effect of amphetamine repeated treatment on the feeding behavior in neuropeptide Y-overexpressing mice.
Topics: Amphetamine; Animals; Anorexia; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Eating; Feeding Behavior; Gene Expression; Homozygote; Male; Mice; Mice, Transgenic; Neuropeptide Y; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2002 |
Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Hallucinogens; Haloperidol; Immunohistochemistry; Male; Motor Activity; Neostriatum; Neuropeptide Y; Nucleus Accumbens; Phencyclidine; Rats; Rats, Wistar; Stereotyped Behavior | 2003 |
Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression.
Topics: Amphetamine; Animals; Appetite; Behavior, Animal; Body Weight; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drinking Behavior; Drug Administration Routes; Drug Administration Schedule; Drug Combinations; Drug Interactions; Eating; Injections, Intraventricular; Male; Neuropeptide Y; Oligonucleotides, Antisense; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2003 |
Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Eating; Feeding and Eating Disorders; Feeding Behavior; Genetic Therapy; Hunger; Levodopa; Locomotion; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum.
Topics: Amphetamine; Animals; Appetite Depressants; Eating; Hypothalamus; Immunohistochemistry; Male; Neuropeptide Y; Rats; Rats, Wistar | 2005 |
Biomarkers of adult and developmental neurotoxicity.
Topics: Amphetamine; Biomarkers; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Neuropeptide Y; Neurotoxicity Syndromes | 2005 |
Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression.
Topics: Amphetamine; Animals; Appetite Depressants; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation; Genes, fos; Genes, jun; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Corpus Striatum; Drug Administration Schedule; Drug Interactions; Extracellular Fluid; Haloperidol; Male; Microdialysis; Neuropeptide Y; Neurotensin; Radioimmunoassay; Rats; Rats, Wistar; Risperidone; Time Factors | 2006 |
Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.
Topics: Amphetamine; Animals; Anorexia; Appetite Depressants; Appetite Regulation; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Feeding Behavior; Injections, Intraventricular; Male; Movement; Nerve Tissue Proteins; Neuropeptide Y; Oligonucleotides, Antisense; Rats; Rats, Wistar; RNA, Messenger | 2007 |
Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Bupropion; Catecholamines; Catheterization; Central Nervous System; Dopamine Uptake Inhibitors; Drug Tolerance; Electrophoresis, Polyacrylamide Gel; Feeding Behavior; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Oligonucleotides, Antisense; Phenylpropanolamine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2007 |
Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling.
Topics: Amphetamine; Animals; Gene Expression Regulation; Hypothalamus; Male; Neuropeptide Y; Oxidative Stress; Protein Kinase C-delta; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Superoxide Dismutase | 2009 |
Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Anorexia; Antisense Elements (Genetics); Appetite Depressants; Behavior, Animal; Binding Sites; Catecholamines; Central Nervous System Stimulants; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Eating; Enzyme Inhibitors; Gene Expression Regulation; Gene Knockdown Techniques; Glutathione Peroxidase; Hypothalamus; Injections, Intraventricular; Isoenzymes; Male; Neuropeptide Y; Protein Kinase C; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; RNA, Messenger; Time Factors; Tyrosine 3-Monooxygenase | 2011 |
NF-κB knockdown can modulate amphetamine-mediated feeding response.
Topics: Amphetamine; Animals; Appetite; Central Nervous System Stimulants; Down-Regulation; Feeding Behavior; Hypothalamus; Male; Neuropeptide Y; NF-kappa B; Oligodeoxyribonucleotides, Antisense; Pro-Opiomelanocortin; Rats; Rats, Wistar; Up-Regulation | 2012 |
Distribution and chemical coding pattern of the cocaine- and amphetamine-regulated transcript (CART) immunoreactivity in the preoptic area of the pig.
Topics: Amphetamine; Animals; Cholecystokinin; Cocaine; Gonadotropin-Releasing Hormone; Immunohistochemistry; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Preoptic Area; Somatostatin; Substance P; Sus scrofa | 2011 |
Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Topics: Amphetamine; Animals; Appetite Depressants; Appetite Regulation; Behavior, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Tolerance; Eating; Gene Expression Regulation; Haloperidol; Hypothalamus; Male; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Oligonucleotides, Antisense; Rats; Rats, Wistar; Receptor, Melanocortin, Type 3; Receptors, Melanocortin; Receptors, Neuropeptide Y | 2012 |
The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Appetite; Arginine; Chromatin Immunoprecipitation; Feeding Behavior; Gene Knockdown Techniques; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Transcription Factor AP-1 | 2013 |
The role of cannabinoid 1 receptor expressing interneurons in behavior.
Topics: Amphetamine; Analgesics; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Conditioning, Psychological; Cyclohexanols; Exploratory Behavior; Glutamate Decarboxylase; Interneurons; Locomotion; Mice; Mice, Transgenic; Mutation; Neuropeptide Y; Receptor, Cannabinoid, CB1; RNA, Messenger; Sensory Gating | 2014 |
Modulation of behavioral networks by selective interneuronal inactivation.
Topics: Amphetamine; Animals; Anxiety; Behavior; Brain; Central Nervous System Stimulants; Cholecystokinin; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Interneurons; Male; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Neuropeptide Y; Olfactory Perception; Proteomics; Social Behavior | 2014 |
Involvement of hypothalamic PI3K-STAT3 signalling in regulating appetite suppression mediated by amphetamine.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Appetite Regulation; Blotting, Western; Hypothalamus; Male; Neurons; Neuropeptide Y; Oligonucleotides, Antisense; Phosphatidylinositol 3-Kinase; Phosphorylation; Pro-Opiomelanocortin; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor | 2014 |
Central dopamine action modulates neuropeptide-controlled appetite via the hypothalamic PI3K/NF-κB-dependent mechanism.
Topics: Amphetamine; Animals; Appetite; Behavior, Animal; Chromones; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Feeding Behavior; Hypothalamus; Male; Morpholines; Neuropeptide Y; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Dopamine; Signal Transduction | 2014 |
Both neuropeptide Y knockdown and Y1 receptor inhibition modulate CART-mediated appetite control.
Topics: Amphetamine; Animals; Appetite Depressants; Appetite Regulation; Hypothalamus; Male; Nerve Tissue Proteins; Neuropeptide Y; Oligonucleotides, Antisense; Peptide Fragments; Pro-Opiomelanocortin; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2015 |
Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats.
Topics: Amphetamine; Animals; Appetite Depressants; Appetite Regulation; Body Weight; Brain; Eating; Feeding Behavior; Free Radical Scavengers; Gene Expression Regulation; Gene Knockdown Techniques; Glutathione Peroxidase; Glutathione Transferase; Isoenzymes; Male; Nerve Tissue Proteins; Neuropeptide Y; Oligonucleotides, Antisense; Oxidative Stress; Rats, Wistar; Signal Transduction; Time Factors | 2015 |
Role of oxidative stress in disrupting the function of negative glucocorticoid response element in daily amphetamine-treated rats.
Topics: Amphetamine; Animals; Appetite Depressants; Brain Chemistry; Corticotropin-Releasing Hormone; Eating; Gene Expression Regulation; Glucocorticoids; Hypothalamus; Male; Neuropeptide Y; Oxidative Stress; Pro-Opiomelanocortin; Promoter Regions, Genetic; Rats; Rats, Wistar; Receptors, Glucocorticoid; Response Elements; RNA, Messenger; Superoxide Dismutase | 2016 |
Participation of ghrelin signalling in the reciprocal regulation of hypothalamic NPY/POMC-mediated appetite control in amphetamine-treated rats.
Topics: Acyltransferases; Amphetamine; Animals; Appetite Regulation; Body Weight; Central Nervous System Stimulants; Eating; Energy Metabolism; Ghrelin; Hypothalamus; Male; Neuropeptide Y; Pro-Opiomelanocortin; Rats; Rats, Wistar; Receptor, Melanocortin, Type 3; Receptors, Ghrelin; Signal Transduction | 2017 |
Role of hypothalamic leptin-LepRb signaling in NPY-CART-mediated appetite suppression in amphetamine-treated rats.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Appetite Regulation; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Leptin; Signal Transduction | 2018 |
Effects of hypergravity on the gene expression of the hypothalamic feeding-related neuropeptides in mice via vestibular inputs.
Topics: Adrenocorticotropic Hormone; Agouti-Related Protein; Amphetamine; Animals; Arcuate Nucleus of Hypothalamus; Cocaine; Gene Expression; Gene Expression Regulation; Hypergravity; Hypothalamus; In Situ Hybridization; Mice; Neuropeptide Y; Orexins; Paraventricular Hypothalamic Nucleus; Pro-Opiomelanocortin; Vestibule, Labyrinth | 2018 |
Role of hypoxia-inducible factor-1α in regulating oxidative stress and hypothalamic neuropeptides-mediated appetite control.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Appetite Regulation; Catalase; Feeding Behavior; Hypothalamus; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Neuropeptide Y; Neuropeptides; NF-kappa B; Oxidative Stress; Phosphatidylinositol 3-Kinases; Pro-Opiomelanocortin; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase | 2019 |
Double immunofluorescent evidence that oxidative stress-associated activation of JNK/AP-1 signaling participates in neuropeptide-mediated appetite control.
Topics: Amphetamine; Animals; Anthracenes; Antioxidants; Appetite Regulation; Feeding Behavior; Fluorescent Antibody Technique; Hypothalamus; Infusions, Intraventricular; JNK Mitogen-Activated Protein Kinases; Male; Nerve Tissue Proteins; Neuropeptide Y; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1 | 2019 |